http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14957806

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 489
issn 2156-6976
issueIdentifier 2
pageRange 469-489
publicationName American journal of cancer research
startingPage 469
bibliographicCitation Aljohani AI, Toss MS, El-Sharawy KA, Mirza S, Ball GR, Green AR, Rakha EA. Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion. Am J Cancer Res. 2022;12(2):469–89. PMID: 35261781; PMCID: PMC8899993.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecd3006ac44a12f9fb2798c0dbf478d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4f2e23ce3125888978d173b5ec85fec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a92f2988b362c47e4f052d3de7b0c867
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cea601041168a64e7bede11d9c3206d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9acf1022fc32e47dc23ddd4bc18dee7e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07608afefe4bf11ff19c79f8d3791fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d96da86317233dbec1ed36477368417b
date 2022
identifier https://pubmed.ncbi.nlm.nih.gov/PMC8899993
https://pubmed.ncbi.nlm.nih.gov/35261781
isPartOf https://portal.issn.org/resource/ISSN/2156-6976
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38854
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c3e3092c60da774d8007592846a09622
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431

Showing number of triples: 1 to 31 of 31.